Assessment of technical heterogeneity among diagnostic tests to detect germline risk variants for hematopoietic malignancies

[1]  G. Huet,et al.  Inherited transmission of the CSF3R T618I mutational hotspot in familial chronic neutrophilic leukemia. , 2019, Blood.

[2]  Ying Wang,et al.  ClinGen Myeloid Malignancy Variant Curation Expert Panel recommendations for germline RUNX1 variants. , 2019, Blood advances.

[3]  F. Solé,et al.  Germline loss-of-function SAMD9 and SAMD9L alterations in adult myelodysplastic syndromes. , 2018, Blood.

[4]  L. Godley,et al.  Hereditary Myelodysplastic Syndrome and Acute Myeloid Leukemia: Diagnosis, Questions, and Controversies , 2018, Current Hematologic Malignancy Reports.

[5]  D. Steensma.  Clinical Implications of Clonal Hematopoiesis , 2018, Mayo Clinic proceedings.

[6]  M. Labopin,et al.  European experience and risk factor analysis of donor cell-derived leukaemias/MDS following haematopoietic cell transplantation , 2018, Leukemia.

[7]  K. Tawana,et al.  Universal genetic testing for inherited susceptibility in children and adults with myelodysplastic syndrome and acute myeloid leukemia: are we there yet? , 2018, Leukemia.

[8]  Sushant A. Patil,et al.  Prognostic tumor sequencing panels frequently identify germ line variants associated with hereditary hematopoietic malignancies. , 2018, Blood advances.

[9]  Lars Bullinger,et al.  Genomics of Acute Myeloid Leukemia Diagnosis and Pathways. , 2017, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[10]  Anna L. Brown,et al.  Novel germ line DDX41 mutations define families with a lower age of MDS/AML onset and lymphoid malignancies. , 2016, Blood.

[11]  J. Fitzgibbon,et al.  Inherited DDX41 mutations: 11 genes and counting. , 2016, Blood.

[12]  S. Miyano,et al.  Inherited and Somatic Defects in DDX41 in Myeloid Neoplasms. , 2015, Cancer cell.

[13]  Paola Giordano,et al.  ANKRD26-related thrombocytopenia and myeloid malignancies. , 2013, Blood.